189 related articles for article (PubMed ID: 32871430)
1. PERK Inhibition Promotes Post-angioplasty Re-endothelialization via Modulating SMC Phenotype Changes.
Wang B; Zhang M; Urabe G; Shirasu T; Guo LW; Kent KC
J Surg Res; 2021 Jan; 257():294-305. PubMed ID: 32871430
[TBL] [Abstract][Full Text] [Related]
2. CTP synthase 1, a smooth muscle-sensitive therapeutic target for effective vascular repair.
Tang R; Cui XB; Wang JN; Chen SY
Arterioscler Thromb Vasc Biol; 2013 Oct; 33(10):2336-44. PubMed ID: 24008161
[TBL] [Abstract][Full Text] [Related]
3. Halofuginone stimulates adaptive remodeling and preserves re-endothelialization in balloon-injured rat carotid arteries.
Guo LW; Wang B; Goel SA; Little C; Takayama T; Shi XD; Roenneburg D; DiRenzo D; Kent KC
Circ Cardiovasc Interv; 2014 Aug; 7(4):594-601. PubMed ID: 25074254
[TBL] [Abstract][Full Text] [Related]
4. Activation of Peroxisome Proliferator-Activated Receptor-δ as Novel Therapeutic Strategy to Prevent In-Stent Restenosis and Stent Thrombosis.
Hytönen J; Leppänen O; Braesen JH; Schunck WH; Mueller D; Jung F; Mrowietz C; Jastroch M; von Bergwelt-Baildon M; Kappert K; Heuser A; Drenckhahn JD; Pieske B; Thierfelder L; Ylä-Herttuala S; Blaschke F
Arterioscler Thromb Vasc Biol; 2016 Aug; 36(8):1534-48. PubMed ID: 27283742
[TBL] [Abstract][Full Text] [Related]
5. Drug-Eluting Stent Targeting Sp-1-Attenuated Restenosis by Engaging YAP-Mediated Vascular Smooth Muscle Cell Phenotypic Modulation.
Huang C; Zhao J; Zhu Y
J Am Heart Assoc; 2020 Jan; 9(1):e014103. PubMed ID: 31880978
[TBL] [Abstract][Full Text] [Related]
6. Endothelial repair in stented arteries is accelerated by inhibition of Rho-associated protein kinase.
Hsiao ST; Spencer T; Boldock L; Prosseda SD; Xanthis I; Tovar-Lopez FJ; Van Beusekom HM; Khamis RY; Foin N; Bowden N; Hussain A; Rothman A; Ridger V; Halliday I; Perrault C; Gunn J; Evans PC
Cardiovasc Res; 2016 Dec; 112(3):689-701. PubMed ID: 27671802
[TBL] [Abstract][Full Text] [Related]
7. Smooth muscle cells-derived CXCL10 prevents endothelial healing through PI3Kγ-dependent T cells response.
Lupieri A; Smirnova NF; Solinhac R; Malet N; Benamar M; Saoudi A; Santos-Zas I; Zeboudj L; Ait-Oufella H; Hirsch E; Ohayon P; Lhermusier T; Carrié D; Arnal JF; Ramel D; Gayral S; Laffargue M
Cardiovasc Res; 2020 Feb; 116(2):438-449. PubMed ID: 31106375
[TBL] [Abstract][Full Text] [Related]
8. Coptisine inhibits neointimal hyperplasia through attenuating Pak1/Pak2 signaling in vascular smooth muscle cells without retardation of re-endothelialization.
Chen Y; Jiang X; Yuan Y; Chen Y; Wei S; Yu Y; Zhou Q; Yu Y; Wang J; Liu H; Hua X; Yang Z; Chen Z; Li Y; Wang Q; Chen J; Wang Y
Atherosclerosis; 2024 Apr; 391():117480. PubMed ID: 38447436
[TBL] [Abstract][Full Text] [Related]
9. Recombinant soluble apyrase APT102 inhibits thrombosis and intimal hyperplasia in vein grafts without adversely affecting hemostasis or re-endothelialization.
Ji Y; Adeola O; Strawn TL; Jeong SS; Chen R; Fay WP
J Thromb Haemost; 2017 Apr; 15(4):814-825. PubMed ID: 28079982
[TBL] [Abstract][Full Text] [Related]
10. A novel PDGF receptor inhibitor-eluting stent attenuates in-stent neointima formation in a rabbit carotid model.
Huang C; Mei H; Zhou M; Zheng X
Mol Med Rep; 2017 Jan; 15(1):21-28. PubMed ID: 27922693
[TBL] [Abstract][Full Text] [Related]
11. Apoptosis in resistance arteries induced by hydrogen peroxide: greater resilience of endothelium versus smooth muscle.
Shaw RL; Norton CE; Segal SS
Am J Physiol Heart Circ Physiol; 2021 Apr; 320(4):H1625-H1633. PubMed ID: 33606587
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological Targeting of Plasminogen Activator Inhibitor-1 Decreases Vascular Smooth Muscle Cell Migration and Neointima Formation.
Ji Y; Weng Z; Fish P; Goyal N; Luo M; Myears SP; Strawn TL; Chandrasekar B; Wu J; Fay WP
Arterioscler Thromb Vasc Biol; 2016 Nov; 36(11):2167-2175. PubMed ID: 27659097
[TBL] [Abstract][Full Text] [Related]
13. Endothelial cell activation of the smooth muscle cell phosphoinositide 3-kinase/Akt pathway promotes differentiation.
Brown DJ; Rzucidlo EM; Merenick BL; Wagner RJ; Martin KA; Powell RJ
J Vasc Surg; 2005 Mar; 41(3):509-16. PubMed ID: 15838487
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of vascular smooth-muscle cell proliferation and arterial restenosis by HO-3867, a novel synthetic curcuminoid, through up-regulation of PTEN expression.
Selvendiran K; Kuppusamy ML; Bratasz A; Tong L; Rivera BK; Rink C; Sen CK; Kálai T; Hideg K; Kuppusamy P
J Pharmacol Exp Ther; 2009 Jun; 329(3):959-66. PubMed ID: 19276401
[TBL] [Abstract][Full Text] [Related]
15. Drug-eluting stent specifically designed to target vascular smooth muscle cell phenotypic modulation attenuated restenosis through the YAP pathway.
Huang C; Zhang W; Zhu Y
Am J Physiol Heart Circ Physiol; 2019 Sep; 317(3):H541-H551. PubMed ID: 31298560
[TBL] [Abstract][Full Text] [Related]
16. A perlecan-inducing compound significantly inhibits smooth muscle cell function and in-stent intimal hyperplasia: novel insights into the diverse biological effects of perlecan.
Segev A; Nili N; Osherov AB; Qiang B; Wong AJ; Pillarisetti S; Strauss BH
EuroIntervention; 2010 May; 6(1):134-40. PubMed ID: 20542809
[TBL] [Abstract][Full Text] [Related]
17. Effect of a novel peptide, WKYMVm- and sirolimus-coated stent on re-endothelialization and anti-restenosis.
Jang EJ; Bae IH; Park DS; Lee SY; Lim KS; Park JK; Shim JW; Sim DS; Jeong MH
J Mater Sci Mater Med; 2015 Oct; 26(10):251. PubMed ID: 26438653
[TBL] [Abstract][Full Text] [Related]
18. Roles of vascular endothelial and smooth muscle cells in the vasculoprotective effect of insulin in a mouse model of restenosis.
Mori Y; Gonzalez Medina M; Liu Z; Guo J; Dingwell LS; Chiang S; Kahn CR; Husain M; Giacca A
Diab Vasc Dis Res; 2021; 18(3):14791641211027324. PubMed ID: 34190643
[TBL] [Abstract][Full Text] [Related]
19. PDGF-receptor tyrosine kinase blocker AG1295 selectively attenuates smooth muscle cell growth in vitro and reduces neointimal formation after balloon angioplasty in swine.
Banai S; Wolf Y; Golomb G; Pearle A; Waltenberger J; Fishbein I; Schneider A; Gazit A; Perez L; Huber R; Lazarovichi G; Rabinovich L; Levitzki A; Gertz SD
Circulation; 1998 May; 97(19):1960-9. PubMed ID: 9609090
[TBL] [Abstract][Full Text] [Related]
20. Targeted inhibitory effect of Lenti-SM22alpha-p27-EGFP recombinant lentiviral vectors on proliferation of vascular smooth muscle cells without compromising re-endothelialization in a rat carotid artery balloon injury model.
Jing L; Wang W; Zhang S; Xie M; Tian D; Luo X; Wang D; Ning Q; Lü J; Wang W
PLoS One; 2015; 10(3):e0118826. PubMed ID: 25760326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
